Evidence map›Paper›PMID 38454301›Full record

ArticleNeurogastroenterology and motility2024

Avoidant/restrictive food intake disorder prevalence is high in children with gastroparesis and functional dyspepsia.

Isha Kaul, Helen Burton-Murray, Salma Musaad, Yiming Mirabile, Danita Czyzewski, Miranda A L van Tilburg, Andrew C Sher, Bruno P Chumpitazi, Robert J Shulman

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Avoidant-Restrictive Food Intake Disorder in Patients With Gastrointestinal Disorders: A Systematic Review.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Isha KaulDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Helen Burton-MurrayHarvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-2059-3256
Salma MusaadDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Yiming MirabileDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Danita CzyzewskiDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Miranda A L van TilburgCape Fear Valley Health, Fayetteville, North Carolina, USA.
Andrew C SherDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Bruno P ChumpitaziDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
Robert J ShulmanDepartment of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.ORCID https://orcid.org/0000-0003-2385-0991
Baylor College of Medicine · USDuke University · USHarvard University · USUniversity of North Carolina at Chapel Hill · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Hashem B El-Serag · 2001 to 2026
$28.3M
Advancing Clinical Science in Pediatric GastroparesisU01DK112194 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Bruno Pedro Chumpitazi, Geoffrey A Preidis · 2016 to 2026
$5.3M
A Biobehavioral Approach to Understand Problematic Avoidant/Restrictive Eating in Adults with Functional DyspepsiaK23DK131334 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BURTON MURRAY, HELEN · 2021 to 2025
$1.1M
NIDDK NIH HHS K23 DK131334NIDDK NIH HHS P30 DK056338NIDDK NIH HHS U01 DK112194NIH HHS
6 · The paper itself

Abstract

backgroundAvoidant/restrictive food intake disorder (ARFID) prevalence in children with gastroparesis (Gp) and/or functional dyspepsia (FD) is unknown. We aimed to identify ARFID prevalence and trajectory over 2 months in children with Gp, FD, and healthy children (HC) using two screening questionnaires. We also explored the frequency of a positive ARFID screen between those with/without delayed gastric emptying or abnormal fundic accommodation.

methodsIn this prospective longitudinal study conducted at an urban tertiary care hospital, patients ages 10-17 years with Gp or FD and age- and gender-matched HC completed two validated ARFID screening tools at baseline and 2-month follow-up: the Nine Item ARFID Screen (NIAS) and the Pica, ARFID, and Rumination Disorder Interview-ARFID Questionnaire (PARDI-AR-Q). Gastric retention and fundic accommodation (for Gp and FD) were determined from gastric emptying scintigraphy. KEY

resultsAt baseline, the proportion of children screening positive for ARFID on the NIAS versus PARDI-AR-Q was Gp: 48.5% versus 63.6%, FD: 66.7% versus 65.2%, HC: 15.3% versus 9.7%, respectively; p < 0.0001 across groups. Of children who screened positive at baseline and participated in the follow-up, 71.9% and 53.3% were positive 2 months later (NIAS versus PARDI-AR-Q, respectively). A positive ARFID screen in Gp or FD was not related to the presence/absence of delayed gastric retention or abnormal fundic accommodation. CONCLUSIONS & INFERENCES: ARFID detected from screening questionnaires is highly prevalent among children with Gp and FD and persists for at least 2 months in a substantial proportion of children. Children with these disorders should be screened for ARFID.

Indexed as

Avoidant Restrictive Food Intake DisorderDyspepsiaGastroparesisAdolescentChildFemaleGastric EmptyingHumansLongitudinal StudiesMalePrevalenceProspective StudiesSurveys and QuestionnairesARFIDdisordered eatingdyspepsiagastroparesisNIASPARDI‐AR‐Q

Identifiers

PMID38454301
PMCPMC11149999
OpenAlexW4392592067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.